Signaling Pathways - MST - Topoisomerases - c-Kit
清除全部
-
A8735 XMU-MP-12 CitationTarget: MSTSummary: MST1/2的强效选择性抑制剂 -
B5954 Dasatinib Monohydrate中文名: 达沙替尼一水合物Target: PDGFR|c-Kit|Bcr-Abl|SrcSummary: ABL\SRC\KIT\PDGFR以及其它酪氨酸激酶抑制剂 -
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: 酪氨酸激酶抑制剂(TKI) -
B5854 Pexidartinib (PLX3397)3 Citation中文名: 培西达替尼Target: FLT3|c-Kit|CSF1RSummary: CSF-1R抑制剂 -
B5835 AZD2932Target: FLT3|VEGFR|PDGFR|c-KitSummary: VEGFR-2\PDGFRβ\Flt-3和c-Kit的抑制剂 -
B4745 (S)-10-Hydroxycamptothecin中文名: 羟喜树碱Target: TopoisomerasesSummary: 拓扑异构酶I抑制剂 -
B7382 Ellipticine中文名: 玫瑰树碱，椭圆玫瑰树碱Target: TopoisomerasesSummary: DNA拓扑异构酶II抑制剂 -
B2295 Pirarubicin1 Citation中文名: 吡柔比星Target: TopoisomerasesSummary: 拓扑异构酶II抑制剂，蒽环类抗生素 -
B1801 Norfloxacin中文名: 诺氟沙星Target: TopoisomerasesSummary: 拓扑异构酶抑制剂 -
B2293 Irinotecan HCl Trihydrate中文名: 盐酸依立替康三水合物Target: TopoisomerasesSummary: 拓扑异构酶I抑制剂